Prosecution Insights
Last updated: August 06, 2026

Nevrivy Patent Law Group P.L.L.C.

14 pending office actions • 10 clients • 12 examiners • 10 art units • 0 of 14 (0%) have an AI response strategy ready

Quality Metrics (n=456 apps, methodology: how we score firms)

84.2%
Allowance Rate
n=456
+0.88σ
Allowance Rate (norm)
n=456
4.6
OAs to Allowance
n=229
+0.14σ
OAs to Allow (norm)
n=229
1324 days
Time to Allowance
n=229
+19.6pp
Interview Lift
n=456
37.9%
RCE Rate
n=456
0.4%
Appeal Rate
n=456

Rejection Performance (% of received rejections ultimately overcome)

82.4%
§101 Overcome
n=51
82.0%
§102 Overcome
n=122
83.8%
§103 Overcome
n=185
80.8%
§112 Overcome
n=177

Specialization & Scale

A61K, A61P, C12N
Top CPC Subclasses
43%
Top-3 CPC Share
n=456
0
Practitioners
n=456
Apps / Practitioner
n=456 (min 20)

Portfolio Summary

14
Total Pending OAs
8
Non-Final OAs
6
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
3
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

9
Hard (64%)
4
Medium (29%)
1
Easy (7%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (14%)
§103 only1 (7%)
§102 only2 (14%)
§112 only1 (7%)
Double-patenting + other1 (7%)
Multi-statute (no §101)7 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

12
Life Sciences
86% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

140 h
Manual time on pending OAs
28 h
Time saved (low, 20%)
49 h
Time saved (mid, 35%)
1.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BREEN, KIMBERLY CATHERINE 2 24.4% +56.7%
MINCHELLA, KAITLYN L 2 27.2% +22.8%
RAGHU, GANAPATHIRAM 1 73.6% +26.4%
KRASNOW, NICHOLAS R 1 66.5% +12.5%
CHATTIN, AMY MARIE 1 71.1% +44.4%
BERA, HENA RAKESHKUMAR 1
SCHLOOP, ALLISON ELIZABETH 1 60.0% +59.3%
PURDY, KYLE A 1 41.0% +36.5%
COLEMAN, BRENDA LIBBY 1 74.7% +15.5%
KWAK, DEAN P 1 58.8% +37.2%

Hard Cases (10)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17255570 METHODS OF TREATING OR PREVENTING MUCORMYCOSIS CHEONG, CHEOM-GIL 25d overdue
18332359 A MULTIPLEX CRISPR BASED ASSAY FOR THE SIMULTANEOUS DETECTION OF CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE SCHLOOP, ALLISON ELIZABETH 18d overdue
17261023 MICROFLUIDIC DEVICE FOR APPLYING PRESSURE TO A CELL ASSEMBLY KWAK, DEAN P 3d overdue
15028253 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES MINCHELLA, KAITLYN L 14d
15489658 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES MINCHELLA, KAITLYN L 21d
18852356 METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE RAGHU, GANAPATHIRAM
18827601 DETECTION OF CREATINE LEVELS USING ENZYME COMPOSITIONS BREEN, KIMBERLY CATHERINE
18569156 THREE-DIMENSIONAL CELL-LADEN BIOINK SCAFFOLDS AND METHODS OF MAKING THE SAME UNDER CRYOGENIC CONDITIONS FOR TISSUE ENGINEERING KRASNOW, NICHOLAS R

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18332359 A MULTIPLEX CRISPR BASED ASSAY FOR THE SIMULTANEOUS DETECTION OF CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE SCHLOOP, ALLISON ELIZABETH 18d overdue
17261023 MICROFLUIDIC DEVICE FOR APPLYING PRESSURE TO A CELL ASSEMBLY KWAK, DEAN P 3d overdue
15028253 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES MINCHELLA, KAITLYN L 14d
15489658 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES MINCHELLA, KAITLYN L 21d
17767783 COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO CELLS PURDY, KYLE A 27d
18852356 METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE RAGHU, GANAPATHIRAM
18827601 DETECTION OF CREATINE LEVELS USING ENZYME COMPOSITIONS BREEN, KIMBERLY CATHERINE
18569156 THREE-DIMENSIONAL CELL-LADEN BIOINK SCAFFOLDS AND METHODS OF MAKING THE SAME UNDER CRYOGENIC CONDITIONS FOR TISSUE ENGINEERING KRASNOW, NICHOLAS R

Client Portfolio (10 clients)

Top Art Units

Art UnitApps
16452
16852
17441
16431
16781
16831
16111
16241
16571
17981

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18852356 METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE The United States Department of Veterans Affairs RAGHU, GANAPATHIRAM §102§103§112 Non-Final OA Pending Sep 27, 2024
18827601 DETECTION OF CREATINE LEVELS USING ENZYME COMPOSITIONS Ip2Ipo Innovations Limited BREEN, KIMBERLY CATHERINE §103§112 Non-Final OA Pending Sep 06, 2024
18569156 THREE-DIMENSIONAL CELL-LADEN BIOINK SCAFFOLDS AND METHODS OF MAKING THE SAME UNDER CRYOGENIC CONDITIONS FOR TISSUE ENGINEERING UNIVERSITY OF MARYLAND, BALTIMORE KRASNOW, NICHOLAS R 1744 §103§112 Non-Final OA Pending Dec 11, 2023
18451671 DETECTION OF ACUTE MYELOID LEUKAEMIA Oxford University Innovation Limited CHATTIN, AMY MARIE 1643 §102 Final Rejection Pending Aug 17, 2023
18276956 GLIOMA THERAPY Imperial College Innovations Limited BERA, HENA RAKESHKUMAR 1678 §101§103§112 Non-Final OA Pending Aug 11, 2023
18332359 A MULTIPLEX CRISPR BASED ASSAY FOR THE SIMULTANEOUS DETECTION OF CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE The Penn State Research Foundation SCHLOOP, ALLISON ELIZABETH 1683 §101§103§112 Non-Final OA 18d overdue Pending Jun 09, 2023
17767783 COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO CELLS UNIVERSITY OF MARYLAND, BALTIMORE PURDY, KYLE A 1611 §103 Non-Final OA 27d Pending Apr 08, 2022
17625059 TREATMENT OF PULMONARY FIBROSIS USING INHIBITORS OF NEU1 SIALIDASE The United States Department of Veterans Affairs COLEMAN, BRENDA LIBBY 1624 §102 Non-Final OA Pending Jan 05, 2022
17172860 COMPOSITIONS COMPRISING PROBIOTICS AND METHODS OF USE THEREOF Imagilin Technology LLC BREEN, KIMBERLY CATHERINE 1657 §103DP Final Rejection Pending Feb 10, 2021
17261023 MICROFLUIDIC DEVICE FOR APPLYING PRESSURE TO A CELL ASSEMBLY Technische Universitaet Wien KWAK, DEAN P 1798 §102§103§112 Final Rejection 3d overdue Pending Jan 17, 2021
17255570 METHODS OF TREATING OR PREVENTING MUCORMYCOSIS Los Angeles Biomedical Research Institute AT Harbor AT Ucla Medical Center CHEONG, CHEOM-GIL 1645 §103§112 Non-Final OA 25d overdue Pending Dec 23, 2020
16331863 THERMOSTABLE VARIANTS OF P. FALCIPARUM PFRH5 WHICH CAN BE PRODUCED IN BACTERIAL CELLS Yeda Research And Development Co. Ltd. ZEMAN, ROBERT A 1645 §112 Final Rejection Pending Mar 08, 2019
15489658 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES UNIVERSITY OF MARYLAND, BALTIMORE MINCHELLA, KAITLYN L 1685 §103§112 Final Rejection 21d Pending Apr 17, 2017
15028253 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES UNIVERSITY OF MARYLAND, BALTIMORE MINCHELLA, KAITLYN L 1685 §102§112Other Final Rejection 14d Pending Apr 08, 2016

Managing Nevrivy Patent Law Group P.L.L.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month